Santosh Kesari Joins GenSpera's SAB
This article was originally published in Scrip
Executive Summary
GenSpera, Inc., a company focusing on cancer, has appointed Santosh Kesari to its scientific advisory board (SAB). Kesari is currently chair of the department of translational neuro-oncology and neurotherapeutics at the John Wayne Cancer Institute and director of neuro-oncology at Providence Saint John's Health Centre.